Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.29735 | 52 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.19808 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.19469 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.08572 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.16892 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.38478 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.34969 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.17559 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.12389 | 48 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.15665 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.19973 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.1286 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.22811 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.19915 | 50 |